| Allison Clark Joe, | |
|
4650 Hawthorne Rd, Ste 3b, Chubbuck, ID 83202-2376 | |
| (208) 237-9833 | |
| (208) 237-1800 |
| Full Name | Allison Clark Joe |
|---|---|
| Gender | Female |
| Speciality | Psychologist |
| Location | 4650 Hawthorne Rd, Chubbuck, Idaho |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104174366 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103T00000X | Psychologist | SE-202663 (Idaho) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Allison Clark Joe, 4650 Hawthorne Rd, Ste 3b, Chubbuck, ID 83202-2376 Ph: (208) 237-9833 | Allison Clark Joe, 4650 Hawthorne Rd, Ste 3b, Chubbuck, ID 83202-2376 Ph: (208) 237-9833 |
News Archive
New research suggests a family of widely used cholesterol-lowering drugs might help protect individuals from serious illness following bacterial infection, including the pneumococcal infections that pose a deadly threat to those with sickle cell disease.
Researchers from McGill University's Rosalind and Morris Goodman Cancer Research Centre, the Research Institute of the McGill University Health Centre, the Dana-Farber Cancer Institute and Harvard Medical School have discovered a gene signature that can accurately predict which breast cancer patients are at risk of relapse, thereby sparing those who are not from the burdens associated with unnecessary treatment.
Celgene International Sàrl announced that data evaluating combination therapy REVLIMID (lenalidomide) and dexamethasone in patients with high-risk smoldering multiple myeloma were presented during the American Society of Hematology's annual meeting in New Orleans, LA. The landmark study demonstrated REVLIMID and dexamethasone prolonged time to progression, including complete responses, with manageable toxicity.
Scientists funded by the National Eye Institute report a novel gene therapy that halts vision loss in a canine model of a blinding condition called autosomal dominant retinitis pigmentosa (adRP). The strategy could one day be used to slow or prevent vision loss in people with the disease. NEI is part of the National Institutes of Health.
› Verified 7 days ago
Hillary Hamilton Locke, PSY.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 4460 Central Way Ste 2, Chubbuck, ID 83202 Phone: 208-237-1711 | |
Mrs. Jeanna Chay Colborn, MA, SE Psychologist Medicare: Not Enrolled in Medicare Practice Location: Sanctuary 4737 Afton Pl, Ste #a, Chubbuck, ID 83202 Phone: 208-417-0623 Fax: 208-417-0641 | |
Liva Rigney-cox, Psychologist Medicare: Not Enrolled in Medicare Practice Location: 4650 Hawthorne Rd, Ste 3b, Chubbuck, ID 83202 Phone: 208-237-9833 Fax: 208-237-1800 | |
Mr. Daniel Lance Traughber, PHD Psychologist Medicare: Accepting Medicare Assignments Practice Location: 4737 Afton Place, Ste A, Chubbuck, ID 83202 Phone: 208-417-0623 Fax: 208-417-0641 | |
Stefane Yeaman, Psychologist Medicare: Not Enrolled in Medicare Practice Location: 4650 Hawthorne Rd, Ste 3b, Chubbuck, ID 83202 Phone: 208-237-9833 Fax: 208-237-1800 | |
Belinda Turley, Psychologist Medicare: Not Enrolled in Medicare Practice Location: 4650 Hawthorne Rd, Ste 3b, Chubbuck, ID 83202 Phone: 208-237-9833 Fax: 208-237-1800 |